ID   UBP22_HUMAN             Reviewed;         525 AA.
AC   Q9UPT9; A0JNS3; Q2NLE2; Q6MZY4; Q8TBS8; Q96IW5;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   13-SEP-2005, sequence version 2.
DT   15-MAR-2017, entry version 146.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 22;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 22;
DE   AltName: Full=Ubiquitin thioesterase 22;
DE   AltName: Full=Ubiquitin-specific-processing protease 22;
GN   Name=USP22; Synonyms=KIAA1063, USP3L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV.
RT   The complete sequences of 100 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 73-525.
RC   TISSUE=Colon endothelium;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=16378762; DOI=10.1016/j.modgep.2005.07.007;
RA   Lee H.-J., Kim M.-S., Shin J.-M., Park T.-J., Chung H.-M., Baek K.-H.;
RT   "The expression patterns of deubiquitinating enzymes, USP22 and
RT   Usp22.";
RL   Gene Expr. Patterns 6:277-284(2006).
RN   [5]
RP   FUNCTION IN HISTONE DEUBIQUITINATION, IDENTIFICATION BY MASS
RP   SPECTROMETRY, IDENTIFICATION IN THE SAGA COMPLEX, AND MUTAGENESIS OF
RP   HIS-471 AND HIS-479.
RX   PubMed=18206972; DOI=10.1016/j.molcel.2007.12.011;
RA   Zhao Y., Lang G., Ito S., Bonnet J., Metzger E., Sawatsubashi S.,
RA   Suzuki E., Le Guezennec X., Stunnenberg H.G., Krasnov A.,
RA   Georgieva S.G., Schuele R., Takeyama K., Kato S., Tora L., Devys D.;
RT   "A TFTC/STAGA module mediates histone H2A and H2B deubiquitination,
RT   coactivates nuclear receptors, and counteracts heterochromatin
RT   silencing.";
RL   Mol. Cell 29:92-101(2008).
RN   [6]
RP   FUNCTION IN HISTONE H2A DEUBIQUITINATION, AND CATALYTIC ACTIVITY.
RX   PubMed=18206973; DOI=10.1016/j.molcel.2007.12.015;
RA   Zhang X.-Y., Varthi M., Sykes S.M., Phillips C., Warzecha C., Zhu W.,
RA   Wyce A., Thorne A.W., Berger S.L., McMahon S.B.;
RT   "The putative cancer stem cell marker USP22 is a subunit of the human
RT   SAGA complex required for activated transcription and cell-cycle
RT   progression.";
RL   Mol. Cell 29:102-111(2008).
RN   [7]
RP   FUNCTION IN HISTONE H2B DEUBIQUITINATION.
RX   PubMed=18469533; DOI=10.4161/cc.7.11.5962;
RA   Zhang X.-Y., Pfeiffer H.K., Thorne A.W., McMahon S.B.;
RT   "USP22, an hSAGA subunit and potential cancer stem cell marker,
RT   reverses the polycomb-catalyzed ubiquitylation of histone H2A.";
RL   Cell Cycle 7:1522-1524(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-129, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Histone deubiquitinating component of the transcription
CC       regulatory histone acetylation (HAT) complex SAGA. Catalyzes the
CC       deubiquitination of both histones H2A and H2B, thereby acting as a
CC       coactivator. Recruited to specific gene promoters by activators
CC       such as MYC, where it is required for transcription. Required for
CC       nuclear receptor-mediated transactivation and cell cycle
CC       progression. {ECO:0000269|PubMed:18206972,
CC       ECO:0000269|PubMed:18206973, ECO:0000269|PubMed:18469533}.
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:18206973}.
CC   -!- SUBUNIT: Component of some SAGA transcription coactivator-HAT
CC       complexes, at least composed of ATXN7, ATXN7L3, ENY2, GCN5L2,
CC       SUPT3H, TAF10, TRRAP and USP22. Within the SAGA complex, ATXN7L3,
CC       ENY2 and USP22 form a subcomplex required for histone
CC       deubiquitination. Interacts directly with ATXN7L3; leading to its
CC       recritment to the SAGA complex. {ECO:0000269|PubMed:18206972}.
CC   -!- INTERACTION:
CC       Q9NRN7:AASDHPPT; NbExp=6; IntAct=EBI-723510, EBI-740884;
CC       Q96AE4:FUBP1; NbExp=3; IntAct=EBI-723510, EBI-711404;
CC       Q13469:NFATC2; NbExp=2; IntAct=EBI-723510, EBI-716258;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q5DU02}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UPT9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UPT9-2; Sequence=VSP_036720;
CC         Note=Ref.2 (AAI10500) sequence differs from that shown due to a
CC         frameshift in position 3. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Moderately expressed in various tissues
CC       including heart and skeletal muscle, and weakly expressed in lung
CC       and liver. {ECO:0000269|PubMed:16378762}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. UBP8 subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH25317.1; Type=Frameshift; Positions=355; Evidence={ECO:0000305};
CC       Sequence=BAA83015.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB028986; BAA83015.1; ALT_INIT; mRNA.
DR   EMBL; BC007196; AAH07196.1; -; mRNA.
DR   EMBL; BC025317; AAH25317.1; ALT_FRAME; mRNA.
DR   EMBL; BC110499; AAI10500.1; ALT_FRAME; mRNA.
DR   EMBL; BC126898; AAI26899.1; -; mRNA.
DR   EMBL; BX640815; CAE45893.1; -; mRNA.
DR   CCDS; CCDS42285.1; -. [Q9UPT9-1]
DR   RefSeq; NP_056091.1; NM_015276.1. [Q9UPT9-1]
DR   UniGene; Hs.462492; -.
DR   ProteinModelPortal; Q9UPT9; -.
DR   SMR; Q9UPT9; -.
DR   BioGrid; 116914; 74.
DR   IntAct; Q9UPT9; 39.
DR   MINT; MINT-1390273; -.
DR   STRING; 9606.ENSP00000261497; -.
DR   MEROPS; C19.035; -.
DR   iPTMnet; Q9UPT9; -.
DR   PhosphoSitePlus; Q9UPT9; -.
DR   BioMuta; USP22; -.
DR   DMDM; 78103328; -.
DR   EPD; Q9UPT9; -.
DR   PaxDb; Q9UPT9; -.
DR   PeptideAtlas; Q9UPT9; -.
DR   PRIDE; Q9UPT9; -.
DR   Ensembl; ENST00000261497; ENSP00000261497; ENSG00000124422. [Q9UPT9-1]
DR   Ensembl; ENST00000537526; ENSP00000440950; ENSG00000124422. [Q9UPT9-2]
DR   GeneID; 23326; -.
DR   KEGG; hsa:23326; -.
DR   UCSC; uc002gym.4; human. [Q9UPT9-1]
DR   CTD; 23326; -.
DR   DisGeNET; 23326; -.
DR   GeneCards; USP22; -.
DR   HGNC; HGNC:12621; USP22.
DR   HPA; HPA044980; -.
DR   MIM; 612116; gene.
DR   neXtProt; NX_Q9UPT9; -.
DR   OpenTargets; ENSG00000124422; -.
DR   PharmGKB; PA37247; -.
DR   eggNOG; KOG1867; Eukaryota.
DR   eggNOG; ENOG410XQQ0; LUCA.
DR   GeneTree; ENSGT00870000136393; -.
DR   HOGENOM; HOG000007260; -.
DR   HOVERGEN; HBG058014; -.
DR   InParanoid; Q9UPT9; -.
DR   KO; K11366; -.
DR   OMA; TANCTIG; -.
DR   OrthoDB; EOG091G09GI; -.
DR   PhylomeDB; Q9UPT9; -.
DR   TreeFam; TF323554; -.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-5689880; Ub-specific processing proteases.
DR   ChiTaRS; USP22; human.
DR   GenomeRNAi; 23326; -.
DR   PRO; PR:Q9UPT9; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000124422; -.
DR   CleanEx; HS_USP22; -.
DR   ExpressionAtlas; Q9UPT9; baseline and differential.
DR   Genevisible; Q9UPT9; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000124; C:SAGA complex; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030374; F:ligand-dependent nuclear receptor transcription coactivator activity; IMP:UniProtKB.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:UniProtKB.
DR   GO; GO:0036459; F:thiol-dependent ubiquitinyl hydrolase activity; TAS:Reactome.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0009790; P:embryo development; NAS:UniProtKB.
DR   GO; GO:0016578; P:histone deubiquitination; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IEA:GOC.
DR   GO; GO:0016574; P:histone ubiquitination; IDA:UniProtKB.
DR   GO; GO:0045931; P:positive regulation of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Alternative splicing; Cell cycle;
KW   Chromatin regulator; Complete proteome; Hydrolase; Metal-binding;
KW   Nucleus; Protease; Reference proteome; Thiol protease; Transcription;
KW   Transcription regulation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    525       Ubiquitin carboxyl-terminal hydrolase 22.
FT                                /FTId=PRO_0000080650.
FT   DOMAIN      176    520       USP.
FT   ZN_FING      61    121       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    185    185       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE    479    479       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES     129    129       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VAR_SEQ       1     57       MVSRPEPEGEAMDAELAVAPPGCSHLGSFKVDNWKQNLRAI
FT                                YQCFVWSGTAEARKRK -> MAPGWPSLSAGSRQEAPQLAA
FT                                GGSAYQAVGRQFQPRATALQGPSQ (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_036720.
FT   MUTAGEN     471    471       H->A: Impairs its function as a positive
FT                                modulator of androgen receptor
FT                                transactivation; when associated with A-
FT                                479. {ECO:0000269|PubMed:18206972}.
FT   MUTAGEN     479    479       H->A: Impairs its function as a positive
FT                                modulator of androgen receptor
FT                                transactivation; when associated with A-
FT                                471. {ECO:0000269|PubMed:18206972}.
FT   CONFLICT     85     85       F -> L (in Ref. 2; AAI26899).
FT                                {ECO:0000305}.
FT   CONFLICT    380    380       K -> T (in Ref. 3; CAE45893).
FT                                {ECO:0000305}.
FT   CONFLICT    496    496       D -> V (in Ref. 2; AAH25317).
FT                                {ECO:0000305}.
SQ   SEQUENCE   525 AA;  59961 MW;  D18BFE84BE8E5915 CRC64;
     MVSRPEPEGE AMDAELAVAP PGCSHLGSFK VDNWKQNLRA IYQCFVWSGT AEARKRKAKS
     CICHVCGVHL NRLHSCLYCV FFGCFTKKHI HEHAKAKRHN LAIDLMYGGI YCFLCQDYIY
     DKDMEIIAKE EQRKAWKMQG VGEKFSTWEP TKRELELLKH NPKRRKITSN CTIGLRGLIN
     LGNTCFMNCI VQALTHTPLL RDFFLSDRHR CEMQSPSSCL VCEMSSLFQE FYSGHRSPHI
     PYKLLHLVWT HARHLAGYEQ QDAHEFLIAA LDVLHRHCKG DDNGKKANNP NHCNCIIDQI
     FTGGLQSDVT CQVCHGVSTT IDPFWDISLD LPGSSTPFWP LSPGSEGNVV NGESHVSGTT
     TLTDCLRRFT RPEHLGSSAK IKCSGCHSYQ ESTKQLTMKK LPIVACFHLK RFEHSAKLRR
     KITTYVSFPL ELDMTPFMAS SKESRMNGQY QQPTDSLNND NKYSLFAVVN HQGTLESGHY
     TSFIRQHKDQ WFKCDDAIIT KASIKDVLDS EGYLLFYHKQ FLEYE
//
